COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03829332
Brief Title: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Non-small Cell Lung Cancer (NSCLC)(MK-7902-007/E7080-G000-314/LEAP-007)

First Submitted : February 1, 2019
First Submitted that Met QC Criteria : February 1, 2019
First Posted : February 4, 2019

Last Update Submitted that Met QC Criteria : October 21, 2020
Last Update Posted : October 22, 2020